| Product NDC: | 42747-726 |
| Proprietary Name: | Sancuso |
| Non Proprietary Name: | granisetron |
| Active Ingredient(s): | 3.1 mg/24h & nbsp; granisetron |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42747-726 |
| Labeler Name: | ProStrakan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022198 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080912 |
| Package NDC: | 42747-726-01 |
| Package Description: | 1 POUCH in 1 CARTON (42747-726-01) > 1 PATCH in 1 POUCH > 168 h in 1 PATCH |
| NDC Code | 42747-726-01 |
| Proprietary Name | Sancuso |
| Package Description | 1 POUCH in 1 CARTON (42747-726-01) > 1 PATCH in 1 POUCH > 168 h in 1 PATCH |
| Product NDC | 42747-726 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | granisetron |
| Dosage Form Name | PATCH |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20080912 |
| Marketing Category Name | NDA |
| Labeler Name | ProStrakan, Inc. |
| Substance Name | GRANISETRON |
| Strength Number | 3.1 |
| Strength Unit | mg/24h |
| Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |